Xylem Net Worth
Xylem Net Worth Breakdown | XYL |
Xylem Net Worth Analysis
Xylem's net worth analysis, or its valuation, is the process of determining the total value of the company. This involves assessing a range of factors, including Xylem's financial performance, assets, liabilities, and potential for growth. The ultimate goal is to provide a clear understanding of Xylem's overall worth, which can help investors make informed investment decisions. There are several methods that can be used to perform Xylem's net worth analysis. One common approach is to calculate Xylem's market capitalization.Another approach is to use the price-to-earnings ratio (P/E ratio), which compares Xylem's stock price to its earnings per share (EPS). Discounted cash flow (DCF) analysis is another popular method for assessing Xylem's net worth. This approach calculates the present value of Xylem's future cash flows, taking into account factors such as growth rate, profitability, and risk. By comparing the present value of Xylem's cash flows to its current stock price, investors can gain a better understanding of the company's overall value. Finally, investors may use comparable company analysis to evaluate Xylem's net worth. This involves comparing Xylem's financial metrics to similar companies in the same industry. By identifying companies with similar financial characteristics, investors can gain insight into Xylem's net worth relative to its peers.
To determine if Xylem is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Xylem's net worth research are outlined below:
| Xylem Inc has a strong financial position based on the latest SEC filings | |
| Over 97.0% of the company outstanding shares are owned by institutional investors | |
| Latest headline from thelincolnianonline.com: Disposition of 4406 shares by Albert Cho of Xylem at 86.76 subject to Rule 16b-3 |
Xylem Quarterly Good Will |
|
Xylem uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Xylem Inc. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Xylem's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 6th of February 2024 Upcoming Quarterly Report | View | |
| 2nd of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 6th of February 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Xylem Target Price Consensus
Xylem target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts' performance other than comparing it to past results via a very sophisticated attribution analysis. Xylem's target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
| 20 | Strong Buy |
Most Xylem analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to help potential investors understand Xylem stock's fair price compared to its market value. Analysts arrive at stock ratings after researching the public financial statements of Xylem Inc, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice Exposure ValuationXylem Target Price Projection
Xylem's current and average target prices are 122.76 and 146.95, respectively. The current price of Xylem is the price at which Xylem Inc is currently trading. On the other hand, Xylem's target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.Target Price
Analyst Consensus On Xylem Target Price
Know Xylem's Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Xylem is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Xylem Inc backward and forwards among themselves. Xylem's institutional investor refers to the entity that pools money to purchase Xylem's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Ubs Asset Mgmt Americas Inc | 2024-12-31 | 3.8 M | Swedbank Ab | 2024-12-31 | 3.7 M | Northern Trust Corp | 2024-12-31 | 3.3 M | Norges Bank | 2024-12-31 | 2.6 M | Goldman Sachs Group Inc | 2024-12-31 | 2.5 M | Bank Of America Corp | 2024-12-31 | 2.4 M | Victory Capital Management Inc. | 2024-12-31 | 2.3 M | Dz Bank Ag Deutsche Zentral-genossenschaftsbank Frankfurt Am Main | 2024-12-31 | 2.1 M | Ubs Group Ag | 2024-12-31 | 2 M | Vanguard Group Inc | 2024-12-31 | 28.6 M | Blackrock Inc | 2024-12-31 | 25.1 M |
Follow Xylem's market capitalization trends
The company currently falls under 'Large-Cap' category with a total capitalization of 29.84 B.Market Cap |
|
Project Xylem's profitablity
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | 0.14 | 0.13 | |
| Return On Capital Employed | 0.08 | 0.11 | |
| Return On Assets | 0.05 | 0.06 | |
| Return On Equity | 0.08 | 0.14 |
When accessing Xylem's net worth, it's important to look at multiple sources and consider different scenarios. For example, gross profit margin measures Xylem's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Xylem's profitability and make more informed investment decisions.
Evaluate Xylem's management efficiency
Xylem Inc has Return on Asset of 0.043 % which means that on every $100 spent on assets, it made $0.043 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.0845 %, implying that it generated $0.0845 on every 100 dollars invested. Xylem's management efficiency ratios could be used to measure how well Xylem manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Xylem's Return On Capital Employed is quite stable compared to the past year. Return On Assets is expected to rise to 0.06 this year, although the value of Return On Tangible Assets will most likely fall to 0.13. At this time, Xylem's Return On Assets are quite stable compared to the past year. Asset Turnover is expected to rise to 0.79 this year, although the value of Other Current Assets will most likely fall to about 170.9 M.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 44.86 | 47.11 | |
| Tangible Book Value Per Share | 2.16 | 2.26 | |
| Enterprise Value Over EBITDA | 17.78 | 13.22 | |
| Price Book Value Ratio | 2.64 | 3.02 | |
| Enterprise Value Multiple | 17.78 | 13.22 | |
| Price Fair Value | 2.64 | 3.02 | |
| Enterprise Value | 14.2 B | 12.6 B |
The strategic vision of Xylem Inc management plays a critical role in its financial performance. By evaluating this vision, we provide insights into the stock's growth potential.
Enterprise Value Revenue 3.602 | Revenue | Quarterly Revenue Growth 0.065 | Revenue Per Share | Return On Equity |
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Xylem insiders, such as employees or executives, is commonly permitted as long as it does not rely on Xylem's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Xylem insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Xylem Corporate Filings
F4 | 11th of March 2025 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
10K | 3rd of March 2025 Annual report required by the U.S. Securities and Exchange Commission (SEC) of a company financial performance | ViewVerify |
8K | 4th of February 2025 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
| 28th of June 2024 Other Reports | ViewVerify |
Xylem Earnings Estimation Breakdown
The calculation of Xylem's earning per share is based on the data from the past 12 consecutive months, used for reporting the company's financial figures. The next projected EPS of Xylem is estimated to be 0.9543 with the future projection ranging from a low of 0.93 to a high of 0.9944. Please be aware that this consensus of annual earnings estimates for Xylem Inc is based on EPS before non-recurring items and includes expenses related to employee stock options.Last Reported EPS
0.93 Lowest | Expected EPS | 0.99 Highest |
Xylem Earnings Projection Consensus
Suppose the current estimates of Xylem's value are higher than the current market price of the Xylem stock. In this case, investors may conclude that Xylem is overpriced and will exhibit bullish sentiment. On the other hand, if the present value is lower than the stock price, analysts may conclude that the market undervalues the equity. These scenarios may suggest that the market is not as efficient as it should be at the estimation time, and Xylem's stock will quickly adjusts to the new information provided by the consensus estimate.
| Number of Analysts | Historical Accuracy | Last Reported EPS | Estimated EPS for 31st of March 2025 | Current EPS (TTM) | |
| 20 | 90.08% | 1.18 | 0.9543 | 3.65 |
Xylem Earnings per Share Projection vs Actual
Actual Earning per Share of Xylem refers to what the company shows during its earnings calls or quarterly reports. The Expected EPS is what analysts covering Xylem Inc predict the company's earnings will be in the future. The higher the earnings per share of Xylem, the better is its profitability. While calculating the Earning per Share, we use the weighted ratio, as the number of shares outstanding can change over time.Xylem Estimated Months Earnings per Share
For an investor who is primarily interested in generating an income out of investing in entities such as Xylem, the EPS ratio can tell if the company is intending to increase its current dividend. Although EPS is an essential tool for investors, it should not be used in isolation. EPS of Xylem should always be considered in relation to other companies to make a more educated investment decision.Xylem Quarterly Analyst Estimates and Surprise Metrics
Earnings surprises can significantly impact Xylem's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2025-02-04 | 2024-12-31 | 1.1253 | 1.18 | 0.0547 | 4 | ||
2024-10-31 | 2024-09-30 | 1.11 | 1.11 | 0.0 | 0 | ||
2024-07-30 | 2024-06-30 | 1.05 | 1.09 | 0.04 | 3 | ||
2024-05-02 | 2024-03-31 | 0.84 | 0.9 | 0.06 | 7 | ||
2024-02-06 | 2023-12-31 | 0.96 | 0.99 | 0.03 | 3 | ||
2023-10-31 | 2023-09-30 | 0.89 | 0.99 | 0.1 | 11 | ||
2023-08-02 | 2023-06-30 | 0.8 | 0.98 | 0.18 | 22 | ||
2023-05-04 | 2023-03-31 | 0.62 | 0.72 | 0.1 | 16 | ||
2023-02-07 | 2022-12-31 | 0.79 | 0.92 | 0.13 | 16 | ||
2022-11-01 | 2022-09-30 | 0.66 | 0.79 | 0.13 | 19 | ||
2022-08-02 | 2022-06-30 | 0.54 | 0.66 | 0.12 | 22 | ||
2022-05-04 | 2022-03-31 | 0.41 | 0.47 | 0.06 | 14 | ||
2022-02-03 | 2021-12-31 | 0.61 | 0.63 | 0.02 | 3 | ||
2021-11-02 | 2021-09-30 | 0.59 | 0.63 | 0.04 | 6 | ||
2021-08-03 | 2021-06-30 | 0.62 | 0.66 | 0.04 | 6 | ||
2021-05-04 | 2021-03-31 | 0.38 | 0.56 | 0.18 | 47 | ||
2021-02-04 | 2020-12-31 | 0.68 | 0.81 | 0.13 | 19 | ||
2020-10-29 | 2020-09-30 | 0.51 | 0.62 | 0.11 | 21 | ||
2020-07-30 | 2020-06-30 | 0.39 | 0.4 | 0.01 | 2 | ||
2020-05-05 | 2020-03-31 | 0.37 | 0.23 | -0.14 | 37 | ||
2020-02-06 | 2019-12-31 | 0.89 | 0.89 | 0.0 | 0 | ||
2019-10-31 | 2019-09-30 | 0.82 | 0.82 | 0.0 | 0 | ||
2019-08-01 | 2019-06-30 | 0.79 | 0.79 | 0.0 | 0 | ||
2019-05-02 | 2019-03-31 | 0.56 | 0.52 | -0.04 | 7 | ||
2019-01-31 | 2018-12-31 | 0.88 | 0.88 | 0.0 | 0 | ||
2018-10-30 | 2018-09-30 | 0.77 | 0.77 | 0.0 | 0 | ||
2018-07-31 | 2018-06-30 | 0.71 | 0.73 | 0.02 | 2 | ||
2018-05-01 | 2018-03-31 | 0.51 | 0.51 | 0.0 | 0 | ||
2018-02-01 | 2017-12-31 | 0.76 | 0.76 | 0.0 | 0 | ||
2017-10-31 | 2017-09-30 | 0.64 | 0.65 | 0.01 | 1 | ||
2017-08-01 | 2017-06-30 | 0.57 | 0.59 | 0.02 | 3 | ||
2017-05-02 | 2017-03-31 | 0.38 | 0.39 | 0.01 | 2 | ||
2017-02-02 | 2016-12-31 | 0.65 | 0.66 | 0.01 | 1 | ||
2016-11-01 | 2016-09-30 | 0.53 | 0.54 | 0.01 | 1 | ||
2016-08-02 | 2016-06-30 | 0.47 | 0.48 | 0.01 | 2 | ||
2016-05-03 | 2016-03-31 | 0.34 | 0.35 | 0.01 | 2 | ||
2016-02-04 | 2015-12-31 | 0.6 | 0.6 | 0.0 | 0 | ||
2015-10-29 | 2015-09-30 | 0.48 | 0.49 | 0.01 | 2 | ||
2015-07-30 | 2015-06-30 | 0.43 | 0.43 | 0.0 | 0 | ||
2015-04-30 | 2015-03-31 | 0.31 | 0.33 | 0.02 | 6 | ||
2015-02-05 | 2014-12-31 | 0.6 | 0.62 | 0.02 | 3 | ||
2014-10-28 | 2014-09-30 | 0.52 | 0.53 | 0.01 | 1 | ||
2014-07-29 | 2014-06-30 | 0.44 | 0.48 | 0.04 | 9 | ||
2014-04-29 | 2014-03-31 | 0.32 | 0.34 | 0.02 | 6 | ||
2014-02-04 | 2013-12-31 | 0.52 | 0.56 | 0.04 | 7 | ||
2013-10-29 | 2013-09-30 | 0.35 | 0.49 | 0.14 | 40 | ||
2013-07-30 | 2013-06-30 | 0.45 | 0.36 | -0.09 | 20 | ||
2013-04-30 | 2013-03-31 | 0.27 | 0.27 | 0.0 | 0 | ||
2013-02-07 | 2012-12-31 | 0.46 | 0.47 | 0.01 | 2 | ||
2012-11-01 | 2012-09-30 | 0.43 | 0.44 | 0.01 | 2 | ||
2012-08-02 | 2012-06-30 | 0.48 | 0.49 | 0.01 | 2 | ||
2012-05-03 | 2012-03-31 | 0.36 | 0.36 | 0.0 | 0 | ||
2012-02-28 | 2011-12-31 | 0.46 | 0.4 | -0.06 | 13 | ||
2011-11-21 | 2011-09-30 | 0.42 | 0.55 | 0.13 | 30 |
Xylem Corporate Directors
| Matthew Latino | Director - Investor Relations | Profile | |
| Victoria Harker | Independent Director | Profile | |
| Surya Mohapatra | Independent Director | Profile | |
| Steven Loranger | Independent Director | Profile |
Already Invested in Xylem Inc?
The danger of trading Xylem Inc is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Xylem is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Xylem. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Xylem Inc is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Xylem Inc is a strong investment it is important to analyze Xylem's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Xylem's future performance. For an informed investment choice regarding Xylem Stock, refer to the following important reports: Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Xylem Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.
Is Industrial Machinery & Supplies & Components space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Xylem. If investors know Xylem will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Xylem listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.211 | Dividend Share 1.44 | Earnings Share 3.65 | Revenue Per Share | Quarterly Revenue Growth 0.065 |
The market value of Xylem Inc is measured differently than its book value, which is the value of Xylem that is recorded on the company's balance sheet. Investors also form their own opinion of Xylem's value that differs from its market value or its book value, called intrinsic value, which is Xylem's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Xylem's market value can be influenced by many factors that don't directly affect Xylem's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Xylem's value and its price as these two are different measures arrived at by different means. Investors typically determine if Xylem is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Xylem's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.